Cargando…

High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity

Alterations affecting high-density lipoproteins (HDLs) are one of the various abnormalities observed in dyslipidemia in type 2 diabetes mellitus (T2DM) and obesity. Kinetic studies have demonstrated that the catabolism of HDL particles is accelerated. Both the size and the lipidome and proteome of H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denimal, Damien, Monier, Serge, Bouillet, Benjamin, Vergès, Bruno, Duvillard, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967905/ https://www.ncbi.nlm.nih.gov/pubmed/36837872 http://dx.doi.org/10.3390/metabo13020253

Ejemplares similares

HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control
por: Denimal, Damien, et al.
Publicado: (2022)

Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities
por: Denimal, Damien, et al.
Publicado: (2022)

Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes
por: Denimal, Damien, et al.
Publicado: (2023)

Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
por: Denimal, Damien, et al.
Publicado: (2023)

Increased body fat mass reduces the association between fructosamine and glycated hemoglobin in obese type 2 diabetes patients
por: Vergès, Bruno, et al.
Publicado: (2020)

Carbamylated lipoproteins in diabetes
por: Denimal, Damien
Publicado: (2023)

Extreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis
por: Denimal, Damien, et al.
Publicado: (2016)

Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review
por: Rouland, Alexia, et al.
Publicado: (2022)

High Density Lipoproteins and Diabetes
por: Cochran, Blake J., et al.
Publicado: (2021)

High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
por: Barter, Philip J.
Publicado: (2013)

Reduced High-Density Lipoprotein Cholesterol Is an Independent Determinant of Altered Bone Quality in Women with Type 2 Diabetes
por: Dule, Sara, et al.
Publicado: (2023)

Diabetes is not associated with COVID-19-related mortality in older institutionalized people
por: Legris, Pauline, et al.
Publicado: (2021)

Circadian Rhythm of Subspecies of Low-Density Lipoprotein-Cholesterol and High-Density Lipoprotein-Cholesterol in Healthy Subjects and Patients with Type 2 Diabetes
por: Hayashi, Toshiyuki, et al.
Publicado: (2023)

Gestational Diabetes Type 2: Variation in High-Density Lipoproteins Composition and Function
por: Pasternak, Yael, et al.
Publicado: (2020)

C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese
por: Dongway, Angelo C, et al.
Publicado: (2015)

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
por: Fonseca, Liliana, et al.
Publicado: (2020)

Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion
por: Chen, Zhongli, et al.
Publicado: (2020)

Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function
por: Stadler, Julia T., et al.
Publicado: (2020)

Association of serum high-density lipoprotein cholesterol with microalbuminuria in type 2 diabetes patients
por: Sun, Xun, et al.
Publicado: (2018)

Effect of metformin on the high‐density lipoprotein proteome in youth with type 1 diabetes
por: Gourgari, Evgenia, et al.
Publicado: (2021)

Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
por: Sheng, Guotai, et al.
Publicado: (2022)

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
por: Colhoun, Helen M., et al.
Publicado: (2020)

Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia
por: Kim, Woojin Scott, et al.
Publicado: (2018)

Altered composition and functional profile of high-density lipoprotein in leprosy patients
por: Lemes, Robertha Mariana R., et al.
Publicado: (2020)

Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
por: Kheniser, Karim G., et al.
Publicado: (2020)

Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
por: Bonilha, Isabella, et al.
Publicado: (2021)

New insights into the mechanism of low high-density lipoprotein cholesterol in obesity
por: Wang, Hao, et al.
Publicado: (2011)

Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein
por: Juhi, Ayesha, et al.
Publicado: (2023)

High-Density Lipoprotein Cholesterol, Obesity, and Mammographic Density in Korean Women: The Healthy Twin Study
por: Sung, Joohon, et al.
Publicado: (2011)

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
por: Hahn, Bevra H, et al.
Publicado: (2008)

High-Density Lipoproteins and the Kidney
por: Strazzella, Arianna, et al.
Publicado: (2021)

The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications
por: Wong, Nathan K. P., et al.
Publicado: (2018)

High -density lipoprotein cholesterol as a predictor for diabetes mellitus
por: Wu, Hong, et al.
Publicado: (2018)

Biosynthesis of high density lipoprotein by chicken liver: nature of nascent intracellular high density lipoprotein
por: Banerjee, D, et al.
Publicado: (1983)

Association between triglyceride to high-density lipoprotein cholesterol ratio and type 2 diabetes risk in Japanese
por: Wang, Huijuan, et al.
Publicado: (2023)

The correlation of triglyceride/high-density lipoprotein cholesterol ratio with muscle mass in type 2 diabetes patients
por: Fu, Qingsong, et al.
Publicado: (2023)

Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults
por: Kawamoto, Ryuichi, et al.
Publicado: (2010)

Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
por: Besler, Christian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g7ms7fum0m3tdp8ptmf6q3t13m